Malaria is one of the most prevalent diseases in Africa and the Plasmodium falciparum species is widely accepted as the most virulent, with a fatality rate of 15 – 20 % of reported cases of infection. While various treatments have been accepted into early stage clinical trials there has been little progress towards a proven vaccine. Pending a long term solution, endemic countries rely heavily on the development of innovative drugs with acute efficacy coupled with rapids mode of action. Until recently the rate of drug action has been measured by light microscopic examination of parasite morphology using blood slides of drug treated parasite cultures at regular time intervals. This technique is tedious and, most importantly, subject to interpretation with regards to distinguishing between viable and comprised parasite cells, thus making it impossible to objectively quantitate the rate of drug action. This study aimed to develop a series of bioassays using the calcein-acetoxymethyl and propidium iodide vitality probes which would allow the rate of drug action on Plasmodium falciparum malaria parasites to be assessed and ranked in relation to each other. A novel bioassay using these fluorescent vitality probes coupled with fluorescence microscopy was developed and optimized and allowed the rate of drug action on malaria parasites to be assessed i) rapidly (in relation to current assay techniques) and ii) in a semi-quantitative manner. Extrapolation to flow cytometry for improved quantification provided favourable rankings of drug killing rates in the pilot study, however, requires further development to increase throughput and approach the ultimate goal of producing a medium-throughput assay for rapidly assessing the rate of action of antimalarial drugs. Attempts to adapt the assay for use in a multiwell plate reader, as well as using ATP measurements as an indication of parasite vitality after drug treatment, was met with erratic results. The viability probes assay as it stands represents an improvement on other assay formats in terms of rapidity and quantification of live/compromised parasites in cultures.

No description available.

Malaria is one of the three most deadly diseases in Africa. Although there are available treatments, their efficacy has been greatly reduced over the past two decades due to the development of resistance to currently available drugs. This has necessitated the search for new and effective antimalarial agents. This project approached the search for new antimalarial compounds in two ways: (i) by screening natural products isolated from marine algae against the Plasmodium parasite and (ii) by modification of selected isolated active compounds to target 1-deoxY-đ-xylulose 5-phosphate reductoisomerase (DXR), an enzyme found in the nonmevalonate isoprenoid biosynthetic pathway of Plasmodium Jalciparum. It was envisaged that such a compound would exhibit dual action on the Plasmodium parasite. Extracts obtained from 22 marine algae were prefractionated by solvent partitioning and were screened for anti plasmodial activity against the chloroquine sensitive (CQS) P. Jalciparum D 10 strain. Overall, 50% of the algae screened produced at least one crude fraction with activity against P. Jalciparum. Extracts of the algae Sargassum heterophyllum, Plocamium cornutum, Amphiroa ephedrea and Pterosiphonia cloiophylla gave the most promising results. Fractionation of S. heterophyllum afforded three tetraprenyltoluquinols (3.1, 3.2 and 3.5) and an all-trans-fucoxanthin (3.6). Three new compounds (4.5, 4.6 and 4.7) and two known halogenated monoterpenes (4.1 and 4.4) were isolated from P. cornutum. Each of the isolated compounds from both S. heterophyllum and P. cornutum showed antiplasmodial activity with IC₅₀ values ranging from 2.0 - 15.3 μM for S. heterophyllum and 13 - 230 μM for P. cornutum. Attempts to synthetically modify halogenated monoterpene 4.4 by dihydroxylation and phosphorylation in order to inhibit the DXR enzyme was unsuccessful. However, the hemiterpene analogue (5.42) of the halogenated monoterpenes was successfully phosphorylated and dihydroxylated to give compound 5.45 which showed promising activity against DXR. The result obtained indicated that the proposed phosphorylation and dihydroxylation of the halogenated monoterpene 4.4 would result in the synthesis of a potent DXR inhibitor and therefore a potential antimalarial agent with dual mode of action on the Plasmodium parasite.

Department of Chemistry / PhD (Chemistry) / This thesis is concerned with the computational study of naphthylisoquinoline alkaloids having antimalarial properties. The study was considered interesting because of the importance of gathering information on antimalarial molecules and because these molecules had not yet been studied computationally. The alkaloids considered in this study had been isolated from tropical lianas belonging to the Dioncophyllaceae and Ancistrodaceae families. They comprise alkaloids with both monomeric and dimeric structures. The monomeric structures consist of one unit and the dimeric ones of two units, with each unit containing a naphthalene moiety and an isoquinoline moiety. 33 monomeric molecules were studied, which represent a large portion of all the monomeric naphthylisoquinoline alkaloids isolated so far. Two dimeric molecules with antimalarial activity were investigated, namely, jozimine A2 and mbandakamine A. A third dimeric molecule, with a structure close to that of jozimine A2 but different activity (michellamine A, anti-HIV) was also calculated for comparison purposes. This work utilised electronic structures methods and involved the conformational study of all the molecules selected to identify the stabilising factors in vacuo and in solution. Two levels of theory (HF/ 6-31G (d,p) and DFT/B3LYP/ 6-31+G(d,p)) were utilised to compare their performance for compounds of this type, also in view of a future study extending to other compounds of the same class. The molecules were firstly studied in vacuo and secondly in three different solvents – chloroform, acetonitrile and water – characterized by different polarities and different H-bonding abilities. Quantum chemical calculations in solution were carried out using the Polarisable Continuum Model (PCM). The main stabilizing factors are the presence and types of intramolecular hydrogen bonds (IHBs), which are the dominant factors, and also the mutual orientation of the moieties. The possible IHBs comprise OH⋯O (or OH⋯N and NH⋯O for mbandakamine A) and other H-bond types interactions such as OH⋯ and CH⋯O (or CH⋯O and CH⋯N for mbandakamine A). The moieties prefer to be perpendicular one to another, which is a common tendency of aromatic vii systems. In monomeric structures, there may be only one OH⋯O and possibly also one of each of the other two types of IHBs interactions. In dimeric structures, there may be up to four (five in mbandakamine A) OH⋯O IHBs simultaneously and also other H-bond type interactions. The results provide a comprehensive picture of the molecular properties of these compounds, such as conformational preferences, dipole moments, HOMO-LUMO energy gaps, harmonic vibrational frequencies, solvent effect and influence of the solvent on molecular properties which respond to polarisation by the solvent. Altogether, these results may contribute to a better understanding of their biological activity and to the design of molecular structures with enhanced biological activity. This is the reason of focusing the efforts on the investigation of chemical and physical properties of these alkaloids molecules. / NRF